Jae Wook Lee Selected Research

Immunoglobulins (Immunoglobulin)

1/2022	Clinical implication of minimal residual disease assessment by next-generation sequencing-based immunoglobulin clonality assay in pediatric B-acute lymphoblastic leukemia.
1/2019	Considerations for monitoring minimal residual disease using immunoglobulin clonality in patients with precursor B-cell lymphoblastic leukemia.
8/2014	Use of intravenous immunoglobulin in a disseminated varicella infection in an immunocompromised child.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jae Wook Lee Research Topics

Disease

17	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2024 - 03/2012
10	Leukemia 03/2024 - 12/2012
10	Neoplasms (Cancer) 09/2021 - 01/2015
7	Infections 06/2019 - 01/2013
6	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 07/2023 - 03/2011
6	Inflammation (Inflammations) 06/2023 - 03/2015
5	Aplastic Anemia (Anemia, Hypoplastic) 01/2022 - 11/2011
5	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021 - 11/2013
5	Bacteremia 06/2019 - 06/2013
4	Hypertension (High Blood Pressure) 01/2021 - 12/2012
3	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2023 - 09/2018
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2022 - 03/2014
3	Fibrosis (Cirrhosis) 01/2022 - 10/2019
3	Hemorrhage 01/2021 - 12/2010
3	Hematologic Neoplasms (Hematological Malignancy) 06/2019 - 06/2013
3	Disease Progression 04/2017 - 05/2014
3	Varicella Zoster Virus Infection 04/2017 - 08/2014
2	Atrial Fibrillation 10/2023 - 01/2023
2	Juvenile Myelomonocytic Leukemia 01/2023 - 01/2023
2	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 01/2013
2	Residual Neoplasm 01/2022 - 01/2019
2	Reperfusion Injury 01/2022 - 01/2019
2	Lymphoma (Lymphomas) 10/2021 - 11/2020
2	Obesity 01/2021 - 04/2012
2	Glomerulonephritis 01/2021 - 01/2016
2	Alzheimer Disease (Alzheimer's Disease) 12/2019 - 09/2018
2	Pathologic Complete Response 06/2019 - 07/2015
2	Hyponatremia 01/2018 - 01/2013
2	Left Ventricular Dysfunction 04/2016 - 01/2015
2	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 03/2016 - 04/2015
2	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 09/2015 - 12/2013
2	Acidosis 12/2014 - 05/2014
2	Pain (Aches) 09/2012 - 07/2009
1	Osteoporosis 03/2024
1	Tumor Lysis Syndrome 01/2024
1	Pyuria 10/2023
1	Ischemia 02/2023
1	Pathologic Processes 01/2023
1	Hematuria 01/2023
1	Neurologic Manifestations (Neurological Manifestations) 01/2023
1	Urolithiasis 01/2023
1	Chronic Renal Insufficiency 01/2022
1	Ureteral Obstruction 01/2022
1	Blast Crisis (Blast Phase) 12/2021
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 11/2021
1	Sepsis (Septicemia) 09/2021
1	Proteinuria 01/2021

Drug/Important Bio-Agent (IBA)

6	Anti-Bacterial Agents (Antibiotics)IBA 09/2021 - 06/2013
4	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2021 - 06/2013
4	Glucose (Dextrose)FDA LinkGeneric 10/2019 - 04/2012
3	SteroidsIBA 01/2024 - 06/2007
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 10/2023 - 10/2014
3	Tyrosine Kinase InhibitorsIBA 07/2023 - 01/2022
3	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 08/2014
3	Imatinib Mesylate (Gleevec)FDA Link 03/2019 - 03/2011
3	Acyclovir (Aciclovir)FDA LinkGeneric 04/2017 - 08/2014
3	IronIBA 04/2016 - 11/2011
2	Insulin (Novolin)FDA Link 03/2024 - 01/2016
2	C-Reactive ProteinIBA 10/2023 - 10/2014
2	Interleukin-6 (Interleukin 6)IBA 01/2023 - 01/2016
2	SodiumIBA 01/2023 - 01/2013
2	Interleukin-17 (Interleukin 17)IBA 01/2021 - 01/2019
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 11/2020 - 10/2014
2	RNA (Ribonucleic Acid)IBA 11/2020 - 01/2018
2	Amyloid (Amyloid Fibrils)IBA 12/2019 - 09/2018
2	AnthracyclinesIBA 01/2019 - 12/2010
2	Vasopressins (Vasopressin)IBA 01/2018 - 02/2014
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2016 - 06/2013
2	fludarabineIBA 01/2016 - 06/2013
2	AlkaliesIBA 12/2014 - 05/2014
2	CreatinineIBA 12/2013 - 09/2012
1	MineralsIBA 03/2024
1	Insulin-Like Growth Factor I (IGF-1)IBA 03/2024
1	CoumarinsIBA 06/2023
1	LipopolysaccharidesIBA 06/2023
1	Therapeutic UsesIBA 06/2023
1	Growth Hormone (Somatotropin)IBA 06/2023
1	Glutamic Acid (Glutamate)FDA Link 02/2023
1	Messenger RNA (mRNA)IBA 01/2023
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2023
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2023
1	Dasatinib (BMS 354825)FDA Link 01/2023
1	ChemokinesIBA 01/2022
1	CytokinesIBA 01/2022
1	Protein Isoforms (Isoforms)IBA 01/2022
1	statticIBA 01/2022
1	ponatinibIBA 12/2021
1	Clofarabine (Clolar)FDA Link 10/2021

Therapy/Procedure

17	Drug Therapy (Chemotherapy) 01/2024 - 12/2010
15	Therapeutics 01/2023 - 12/2012
15	Hematopoietic Stem Cell Transplantation 12/2022 - 03/2012
8	Cell Transplantation 01/2023 - 03/2015
5	Transplantation 01/2021 - 01/2013
4	Remission Induction 01/2024 - 12/2010
3	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 01/2022 - 01/2021
2	Cranial Irradiation 11/2016 - 04/2012
1	Radiotherapy 06/2023
1	Central Venous Catheters 09/2021
1	Catheters 09/2021
1	Thoracotomy 01/2021